



Fast, Accurate, Affordable, and Scalable Pathogen Screening
The Avicena Sentinel is the world’s fastest and most scalable molecular diagnostics platform.
Available in two versions, the Sentinel ULTRA and Sentinel Mini cater to diverse testing needs, making it economically viable for both low and high-volume scenarios.
With accuracy comparable to PCR, the Avicena Sentinel outperforms in speed and affordability, while preserving the capability to screen for multiple pathogens simultaneously.
Simply swab your mouth with our microswab to gather the optimal saliva volume.
Secure the swab in the provided barcode-labeled sample tube that contains a stabilising buffer solution.
Sentinel is flexible and can rapidly adapt to test for current and emerging pathogen threats
Lumpy Skin Disease
Japanese Encephalitis Virus
Monkeypox
Zika Virus
Dengue
Malaria
Bioengineered Pathogens
HIV
Hepatitis B
Hepatitis C
Drug-Resistant Tuberculosis
MRSA
VRE
Pseudomonas
Acinetobacter
Human & Zoonotic influenza
Emerging Pandemic Flu Threats
Up to 384 hourly throughput
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting
Up to 100,000 daily throughput
Up to 10x faster than PCR
Continuous Flow Processing
Fully Automated
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting
Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.
CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.